Insight of neonicotinoid insecticides: Exploring exposure, mechanisms in non-target organisms, and removal technologies

IF 9.1 2区医学 Q1 PHARMACOLOGY & PHARMACY

Pharmacological research Pub Date : 2024-09-19 DOI:10.1016/j.phrs.2024.107415

Yuanyuan Zhang , Wanxuan Zhu , Ying Wang , Xueli Li , Jianxin Lv , Jiaoyang Luo , Meihua Yang

{"title":"Insight of neonicotinoid insecticides: Exploring exposure, mechanisms in non-target organisms, and removal technologies","authors":"Yuanyuan Zhang , Wanxuan Zhu , Ying Wang , Xueli Li , Jianxin Lv , Jiaoyang Luo , Meihua Yang","doi":"10.1016/j.phrs.2024.107415","DOIUrl":null,"url":null,"abstract":"<div><div>Neonicotinoid insecticides (NEOs) have garnered global attention due to their selective toxicity to insects and minimal impact on mammals. However, growing concerns about their extensive use and potential adverse effects on the ecological environment and non-target organisms necessitate further investigation. This study utilized bibliometric tools to analyze Web of Science data from 2003 to 2024, elucidating the current research landscape, identifying key research areas, and forecasting future trends related to NEOs. This paper provides an in-depth analysis of NEO exposure in non-target organisms, including risk assessments for various samples and maximum residue limits established by different countries. Additionally, it examines the impacts and mechanisms of NEOs on non-target organisms. Finally, it reviews the current methods for NEO removal and degradation. This comprehensive analysis provides valuable insights for regulating NEO usage and addressing associated exposure challenges.</div></div>","PeriodicalId":19918,"journal":{"name":"Pharmacological research","volume":"209 ","pages":"Article 107415"},"PeriodicalIF":9.1000,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacological research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1043661824003608","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

Abstract

Neonicotinoid insecticides (NEOs) have garnered global attention due to their selective toxicity to insects and minimal impact on mammals. However, growing concerns about their extensive use and potential adverse effects on the ecological environment and non-target organisms necessitate further investigation. This study utilized bibliometric tools to analyze Web of Science data from 2003 to 2024, elucidating the current research landscape, identifying key research areas, and forecasting future trends related to NEOs. This paper provides an in-depth analysis of NEO exposure in non-target organisms, including risk assessments for various samples and maximum residue limits established by different countries. Additionally, it examines the impacts and mechanisms of NEOs on non-target organisms. Finally, it reviews the current methods for NEO removal and degradation. This comprehensive analysis provides valuable insights for regulating NEO usage and addressing associated exposure challenges.

查看原文本刊更多论文

透视新烟碱类杀虫剂：探索非目标生物的接触、机理和清除技术。

新烟碱类杀虫剂（NEOs）因其对昆虫的选择性毒性和对哺乳动物的最小影响而备受全球关注。然而，人们越来越关注其广泛使用及其对生态环境和非目标生物的潜在不利影响，因此有必要对其进行进一步调查。本研究利用文献计量学工具分析了 2003 年至 2024 年的 Web of Science 数据，阐明了当前的研究状况，确定了关键研究领域，并预测了与近地天体有关的未来趋势。本文深入分析了非目标生物接触近地天体的情况，包括各种样本的风险评估和不同国家规定的最大残留限量。此外，本文还研究了近地天体对非目标生物的影响和机制。最后，报告回顾了目前去除和降解近地物体的方法。这一全面分析为规范近地天体的使用和应对相关的暴露挑战提供了宝贵的见解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacological research 医学-药学

CiteScore

18.70

自引率

3.20%

发文量

491

审稿时长

8 days

期刊介绍： Pharmacological Research publishes cutting-edge articles in biomedical sciences to cover a broad range of topics that move the pharmacological field forward. Pharmacological research publishes articles on molecular, biochemical, translational, and clinical research (including clinical trials); it is proud of its rapid publication of accepted papers that comprises a dedicated, fast acceptance and publication track for high profile articles.